跳至主要内容
临床试验/NCT01337531
NCT01337531Unknown2 期

Recombinant FSH Versus Highly Purified FSH in PCOS Patients Undergoing Control Ovarian Stimulation and IVF: a Prospective Randomized Study

Genesis Center for Fertility & Human Pre-Implantation Genetics1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
200
试验地点
1
主要终点
Ovarian Response

研究概览

简要总结

Control ovarian stimulation responses, pregnancy and miscarriage rates are indifferent when either recombinant or highly purified follicle stimulating hormone (FSH) is used.

详细描述

Patients will be randomized using sealed and numbered envelopes and will be assigned to receive a similar ovarian stimulation regime incorporating either Gonal-F or highly purified Fostimon as the hormonal analog. Ovarian response using either of the two compounds, pregnancy rates and miscarriage rates will be compared to define possible statistical significance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Primary infertility
  • No other fertility manifestation

排除标准

  • Secondary infertility

研究组 & 干预措施

gonadotropin

Experimental

recombinant or highly purified gonadotropin

干预措施: Gonal-F, Fostimon (Drug)

Gonadotropins

Active Comparator

recombinant versus highly purified gonadotropin

干预措施: Gonal-F, Fostimon (Drug)

结局指标

主要结局

Ovarian Response

时间窗: 0-15 days post gonadotropin administration

次要结局

  • Pregnancy rate(12-15 days post embryo replacement)

研究者

发起方
Genesis Center for Fertility & Human Pre-Implantation Genetics
申办方类型
Other

研究点 (1)

Loading locations...

相似试验